TFAP2D (transcription factor AP-2 delta) is a sequence-specific DNA-binding transcription factor that regulates gene expression by binding to consensus sequences and activating or suppressing target genes involved in critical developmental and cellular processes 1. As a member of the AP-2 family, TFAP2D functions primarily as a positive regulator of RNA polymerase II-mediated transcription 2. Mechanistically, TFAP2D plays a pivotal role in nervous system development, particularly in specifying excitatory neurons of the basolateral amygdala complex, claustrum, and piriform cortex 2. Its expression is conserved across species, including humans, in developing brain regions that form reciprocal connections with the prefrontal cortex 2. TFAP2D dosage critically influences developmental trajectories, affecting basolateral amygdala size and connectivity in a dose-dependent manner 2. Beyond neurodevelopment, TFAP2D is implicated in epigenetic aging processes conserved between mammals and amphibians, with age-related methylation changes occurring in tfap2d 3. Clinically, TFAP2D upregulation associates with aggressive prostate cancer phenotypes, particularly in ERG-negative tumors, correlating with advanced staging, high Gleason grade, and genomic instability 4. Additionally, TFAP2D variants show associations with elite strength athlete status as part of polygenic strength profiles 5. A polymorphic Alu element flanking TFAP2D distinguishes humans from other primates, potentially affecting gene regulation 6. Disrupted TFAP2D-regulated networks contribute to fertilization failure phenotypes 7.